Management of Hypertension, Obesity, Lipids, and Diabetes with Glucagon-like Peptide 1 Receptor Agonists

Hyperglycemia is considered one of the main risk factors for the development of cardiovascular diseases, and the situation becomes worse if the condition is associated with uncontrolled hypertension, dyslipidemia, and overweight or obesity. Since the first glucagon-like peptide 1 receptor agonist (G...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hridish Narayan Chakravarti, Jothydev Kesavadev, Rajiv Kovil, Debmalya Sanyal, Sambit Das, Nirmalya Roy, Dilip Kumar, Binayak Deb, Soumyabrata Roy Chaudhuri, Pankaj Aneja
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	International Journal of Diabetes and Technology
Assuntos:	atherosclerotic cardiovascular disease glucagon-like peptide receptor agonists hypertension oral semaglutide type 2 diabetes
Acceso en liña:	https://journals.lww.com/10.4103/ijdt.ijdt_11_24
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!